Start Date
August 31, 2017
Primary Completion Date
August 17, 2017
Study Completion Date
June 30, 2022
Nivolumab
Nivolumab will be given as an intravenous infusion at a dose of 240 mg every 2 weeks for at least 6 months.
Pazopanib
Pazopanib given at a dose of 800 mg by mouth daily.
New York University School of Medicine, New York
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
NYU Langone Health
OTHER